Track the CERO THERAPEUTICS HOLDINGS, INC. stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €451k. The latest transaction was filed on 4 April 2025 (Levée d'options). Among the most active insiders: ATWOOD BRIAN G. All data is free.
18
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€589,415
4 ops.
Sell Volume
22Σ signal
Buys n/a€589,415 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
5,828 sharesClass A Common StockSEC:0001213900-24-015034:0
18 of 18 declarations
Acerca de CERO THERAPEUTICS HOLDINGS, INC.
CERO Therapeutics Holdings, Inc. es una empresa centrada en el desarrollo de terapias innovadoras para tratar enfermedades graves. Cotiza en NASDAQ bajo el ticker CERO.